2022
DOI: 10.3389/fonc.2022.976143
|View full text |Cite
|
Sign up to set email alerts
|

The role transition of radiotherapy for the treatment of liver cancer in the COVID-19 era

Abstract: The uncontrollable COVID-19 crises in the SARS-CoV-2 high-prevalence areas have greatly disrupted the routine treatment of liver cancer and triggered a role transformation of radiotherapy for liver cancer. The weight of radiotherapy in the treatment algorithm for liver cancer has been enlarged by the COVID-19 pandemic, which is helpful for the optimal risk-benefit profile.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 41 publications
(98 reference statements)
0
0
0
Order By: Relevance